Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    19586656 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol
Condition: Cervical Intraepithelial Neoplasia
Interventions: Drug: Imiquimod;   Procedure: LLETZ
2 Enrolling by invitation Evaluation of Long-term HPV Vaccine Efficacy
Condition: Uterine Cervical Cancer
Intervention: Procedure: Screening for cervical cancer
3 Completed
Has Results
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
Condition: Infections, Papillomavirus
Interventions: Biological: Cervarix™;   Biological: Havrix™-based investigational formulation

Indicates status has not been verified in more than two years